Disruption of acute opioid dependence by antisense oligodeoxynucleotides targeting neurogranin

Brain Research

Volumn 1143, Issue 1, 2007, Pages 78-82

  Tang, Lei ^a   Shukla, Pradeep K ^a   Wang, Zaijie Jim ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

CaMKII; Dependence; Neurogranin; Opioid; PKC; RC3

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MORPHINE; NALOXONE; NEUROGRANIN; OPIATE; PROTEIN KINASE (CALCIUM,CALMODULIN) II; SODIUM CHLORIDE;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; JUMPING; MALE; MOUSE; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TREATMENT DURATION; WITHDRAWAL REFLEX;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; DOWN-REGULATION; INJECTIONS, INTRA-ARTICULAR; MALE; MICE; MICE, INBRED ICR; MODELS, BIOLOGICAL; MORPHINE; MORPHINE DEPENDENCE; NEUROGRANIN; OLIGONUCLEOTIDES, ANTISENSE; THIONUCLEOTIDES;

MUS;

EID: 33947303389     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.01.058     Document Type: Article

References (25)

1. Aley K.O., and Levine J.D. Different mechanisms mediate development and expression of tolerance and dependence for peripheral mu-opioid antinociception in rat. J. Neurosci. 17 (1997) 8018-8023
2. Aley K.O., and Levine J.D. Dissociation of tolerance and dependence for opioid peripheral antinociception in rats. J. Neurosci. 17 (1997) 3907-3912
3. 2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice. J. Pharmacol. Exp. Ther. 277 (1996) 484-490
4. Bohn L.M., Lefkowitz R.J., and Caron M.G. Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice. J. Neurosci. 22 (2002) 10494-10500
5. 2+-calmodulin and protein kinase Cs: a hypothetical synthesis of their conflicting convergences on shared substrate domains. Trends Neurosci. 22 (1999) 12-16
6. Colbran R.J. Targeting of calcium/calmodulin-dependent protein kinase II. Biochem. J. 378 (2004) 1-16
7. Guitart X., Thompson M.A., Mirante C.K., Greenberg M.E., and Nestler E.J. Regulation of cyclic AMP response element-binding protein (CREB) phosphorylation by acute and chronic morphine in the rat locus coeruleus. J. Neurochem. 58 (1992) 1168-1171
8. Huang K.P., Huang F.L., Li J., Schuck P., and McPhie P. Calcium-sensitive interaction between calmodulin and modified forms of rat brain neurogranin/RC3. Biochemistry 39 (2000) 7291-7299
9. Huang K.P., Huang F.L., Jager T., Li J., Reymann K.G., and Balschun D. Neurogranin/RC3 enhances long-term potentiation and learning by promoting calcium-mediated signaling. J. Neurosci. 24 (2004) 10660-10669
10. Koob G.F., and Nestler E.J. The neurobiology of drug addiction. J. Neuropsychiatry Clin. Neurosci. 9 (1997) 482-497
11. Lane-Ladd S.B., Pineda J., Boundy V.A., Pfeuffer T., Krupinski J., Aghajanian G.K., and Nestler E.J. CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J. Neurosci. 17 (1997) 7890-7901
12. Maldonado R., Blendy J.A., Tzavara E., Gass P., Roques B.P., Hanoune J., and Schutz G. Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science 273 (1996) 657-659
13. Matthews R.P., Guthrie C.R., Wailes L.M., Zhao X., Means A.R., and McKnight G.S. Calcium/calmodulin-dependent protein kinase types II and IV differentially regulate CREB-dependent gene expression. Mol. Cell Biol. 14 (1994) 6107-6116
14. Nestler E.J. Molecular neurobiology of addiction. Am. J. Addict. 10 (2001) 201-217
15. Prichard L., Deloulme J.C., and Storm D.R. Interactions between neurogranin and calmodulin in vivo. J. Biol. Chem. 274 (1999) 7689-7694
16. Quillan J.M., Carlson K.W., Song C., Wang D., and Sadee W. Differential effects of mu-opioid receptor ligands on Ca(2+) signaling. J. Pharmacol. Exp. Ther. 302 (2002) 1002-1012
17. 2+/calmodulin dependent protein kinase II in opioid tolerance and dependence. Neurosci. Lett. 404 (2006) 266-269
18. 2+ from intracellular stores in transfected neuro2a cells by activation of multiple opioid receptor subtypes. Biochem. Pharmacol. 54 (1997) 809-818
19. 2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity. Genes Dev. 8 (1994) 2527-2539
20. Tang L., Shukla P.K., Wang L.X., and Wang Z.J. Reversal of morphine antinociceptive tolerance and dependence by the acute supraspinal inhibition of Ca(2+)/calmodulin-dependent protein kinase II. J. Pharmacol. Exp. Ther. 317 (2006) 901-909
21. Tang L., Shukla P.K., and Wang Z.J. Attenuation of opioid tolerance by antisense oligodeoxynucleotides targeting neurogranin. Eur. J. Pharmacol. 542 (2006) 106-107
22. Wahlestedt C., Salmi P., Good L., Kela J., Johnsson T., Hokfelt T., Broberger C., Porreca F., Lai J., Ren K., Ossipov M., Koshkin A., Jakobsen N., Skouv J., Oerum H., Jacobsen M.H., and Wengel J. Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 5633-5638
23. Wang Z.J., and Wang L.X. Phosphorylation: a molecular switch in opioid tolerance. Life Sci. 79 (2006) 1681-1691
24. Watson J.B., Battenberg E.F., Wong K.K., Bloom F.E., and Sutcliffe J.G. Subtractive cDNA cloning of RC3, a rodent cortex-enriched mRNA encoding a novel 78 residue protein. J. Neurosci. Res. 26 (1990) 397-408
25. Wu J., Li J., Huang K.P., and Huang F.L. Attenuation of protein kinase C and cAMP-dependent protein kinase signal transduction in the neurogranin knockout mouse. J. Biol. Chem. 277 (2002) 19498-19505